文献速递核素与放射性配体治疗放射性药物与辐射防护

医疗事件:甲状腺功能亢进患者意外口服177Lu-PSMA

Medical Event: Accidental Oral Administration of 177Lu-PSMA to a Patient With Hyperthyroidism.
PubMed 文献 · Clin Nucl Med · 2020-01-01

一名74岁甲状腺功能亢进女性在转诊接受放射性碘治疗时,被意外口服给予60 mCi的Lu-PSMA而非碘。发现该医疗事件后立即采取水化、止吐和泻药等辐射防护措施,患者无任何症状。摄入后20和90小时行腹盆腔及头颈部静态采集,显示显著肠道活性以及肾脏、膀胱、唾液腺和泪腺的轻度全身活性。

要点

  • 74岁甲亢女性被意外口服60 mCi的Lu-PSMA而非放射性碘。
  • 立即采取水化、止吐和泻药等辐射防护措施,患者无症状。
  • 摄入后20和90小时显像示显著肠道活性及肾脏、膀胱、唾液腺和泪腺轻度活性。

核心结论

  • 意外口服60 mCi的Lu-PSMA后患者无症状,显像显示显著肠道活性及肾脏、膀胱、唾液腺和泪腺轻度全身活性。

研究设计与样本

  • 本文为医疗事件病例报告,对象为一名74岁甲状腺功能亢进女性,因转诊接受放射性碘治疗而意外口服60 mCi的Lu-PSMA。

主要发现

  • 患者被意外口服给予60 mCi的Lu-PSMA而非碘。
  • 发现事件后立即采取水化、止吐和泻药等辐射防护措施,患者无任何症状。
  • 摄入后20和90小时行腹盆腔及头颈部静态采集,显示显著肠道活性以及肾脏、膀胱、唾液腺和泪腺的轻度全身活性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 74-year-old woman with hyperthyroidism was referred for radioiodine therapy. The patient was accidentally given 60 mCi of Lu-PSMA orally instead of I. Upon discovery of this medical event, we immediately started radiation protective actions including hydration, antiemetics, and laxatives. The patients did not have any symptoms. Static acquisition was performed from the abdominal-pelvic and head and neck regions at 20 and 90 hours after ingestion, which showed prominent intestinal activity and mild systemic activity in the kidneys, bladder, salivary, and lacrimal glands.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zarehparvar Moghadam S, Aghaee A, Esmatinia M, et al. Medical Event: Accidental Oral Administration of 177Lu-PSMA to a Patient With Hyperthyroidism. Clin Nucl Med. 2020. PMID: 32349091. doi:10.1097/RLU.0000000000003026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。